📑NHS National Pharmaceuticals Transition 2020_2
Procurement process summary
This process is to purchase NHS National Pharmaceuticals Transition 2020_2.
This contract was awarded by 🇬🇧 The NHS Commissioning Board (operating under the name of NHS England) for an amount of GBP 16,760,000 to 1 supplier. It was published on 2020-11-06 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇬🇧 The NHS Commissioning Board (operating under the name of NHS England) Buying unitnot reported Publication date2020-11-06 Contest statusnot reported DescriptionNHS National Pharmaceuticals Transition 2020_2Offer reference number: CM/PHG/20/5618Period of framework agreement: the total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months).Potential periods of call-offs under the framework agreement.Transition products:-- LSNE 1 December 2020 to 30 September 2021 (10 months),-- NWLN 1 December 2020 to 31 January 2022 (14 months),-- CESW 1 December 2020 to 30 June 2022 (19 months).Hospital only products:All regions 1 December 2020 to 31 January 2022 (14 months).Products on the framework include (but are not limited to):-- Ambrisentan-- Deferiprone-- Fosaprepitant-- Micafungin-- Noradrenaline (RTU presentations only)-- Oseltamivir-- Oxycodone/Naloxone (combination)-- Prasugrel-- Solifenacin-- Temsirolimus-- Thalidomide-- Tipranavir-- Tolvaptan-- Co-Amoxiclav-- Valganciclovir-- Valaciclovir-- Piperacillin/Tazobactam Pdr for Inj Vial 4 g/500 mg.Awards
This award was granted to Sintetica Ltd by The NHS Commissioning Board (operating under the name of NHS England) for an amount of GBP 16,760,000. The procurement process was conducted through open for the category of goods. This is award number 12.
This contract has multiple awards. This is award number 12. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇬🇧 Sintetica Ltd | GBP 16,760,000 | 12 |
Market context and opportunities
The execution of this contract allows the entity The NHS Commissioning Board (operating under the name of NHS England) to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUK_ocds-70d2nz-b0cc2860-4c18-44a9-9087-d2a0d627bda0-award-12Publication date2020-11-06Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
